# Oral Melatonin as Premedication During MAC for Patients Undergoing Loco-regional Chronic Subdural Hematoma Evacuation

> **NCT03732963** · PHASE1 · COMPLETED · sponsor: **Cairo University** · enrollment: 40 (actual)

## Conditions studied

- Monitored Anaesthesia Care
- Loco-regional Chronic Subdural Hematoma Evacuation

## Interventions

- **DRUG:** Placebo (Group P)
- **DRUG:** Melatonin (Group M)

## Key facts

- **NCT ID:** NCT03732963
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-05
- **Primary completion:** 2018-11-05
- **Final completion:** 2018-11-07
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2018-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03732963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03732963, "Oral Melatonin as Premedication During MAC for Patients Undergoing Loco-regional Chronic Subdural Hematoma Evacuation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03732963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*